Skip to main content
Top
Published in: Annals of Intensive Care 1/2016

Open Access 01-12-2016 | Research

Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis

Authors: Kent W. Stewart, Christopher G. Pretty, Hamish Tomlinson, Felicity L. Thomas, József Homlok, Szabó Némedi Noémi, Attila Illyés, Geoffrey M. Shaw, Balázs Benyó, J. Geoffrey Chase

Published in: Annals of Intensive Care | Issue 1/2016

Login to get access

Abstract

Background

The changes in metabolic pathways and metabolites due to critical illness result in a highly complex and dynamic metabolic state, making safe, effective management of hyperglycemia and hypoglycemia difficult. In addition, clinical practices can vary significantly, thus making GC protocols difficult to generalize across units.The aim of this study was to provide a retrospective analysis of the safety, performance and workload of the stochastic targeted (STAR) glycemic control (GC) protocol to demonstrate that patient-specific, safe, effective GC is possible with the STAR protocol and that it is also generalizable across/over different units and clinical practices.

Methods

Retrospective analysis of STAR GC in the Christchurch Hospital Intensive Care Unit (ICU), New Zealand (267 patients), and the Gyula Hospital, Hungary (47 patients), is analyzed (2011–2015). STAR Christchurch (BG target 4.4–8.0 mmol/L) is also compared to the Specialized Relative Insulin and Nutrition Tables (SPRINT) protocol (BG target 4.4–6.1 mmol/L) implemented in the Christchurch Hospital ICU, New Zealand (292 patients, 2005–2007). Cohort mortality, effectiveness and safety of glycemic control and nutrition delivered are compared using nonparametric statistics.

Results

Both STAR implementations and SPRINT resulted in over 86 % of time per episode in the blood glucose (BG) band of 4.4–8.0 mmol/L. Patients treated using STAR in Christchurch ICU spent 36.7 % less time on protocol and were fed significantly more than those treated with SPRINT (73 vs. 86 % of caloric target). The results from STAR in both Christchurch and Gyula were very similar, with the BG distributions being almost identical. STAR provided safe GC with very few patients experiencing severe hypoglycemia (BG < 2.2 mmol/L, <5 patients, 1.5 %).

Conclusions

STAR outperformed its predecessor, SPRINT, by providing higher nutrition and equally safe, effective control for all the days of patient stay, while lowering the number of measurements and interventions required. The STAR protocol has the ability to deliver high performance and high safety across patient types, time, clinical practice culture (Christchurch and Gyula) and clinical resources.
Literature
1.
go back to reference Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8.CrossRefPubMed Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8.CrossRefPubMed
2.
go back to reference Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041–7.CrossRefPubMed Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041–7.CrossRefPubMed
3.
go back to reference McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–24.CrossRefPubMed McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–24.CrossRefPubMed
4.
go back to reference Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471–8.CrossRefPubMed Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471–8.CrossRefPubMed
5.
go back to reference Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244–52.CrossRefPubMed Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244–52.CrossRefPubMed
6.
go back to reference Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008–13.CrossRefPubMed Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008–13.CrossRefPubMed
7.
go back to reference Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRefPubMed Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRefPubMed
8.
go back to reference Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong XW, Lin J, Lotz T, Lee D, Hann C. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care. 2008;12:R49.CrossRefPubMedPubMedCentral Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong XW, Lin J, Lotz T, Lee D, Hann C. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care. 2008;12:R49.CrossRefPubMedPubMedCentral
9.
go back to reference Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992–1000.CrossRefPubMed Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992–1000.CrossRefPubMed
10.
go back to reference Chase JG, Pretty CG, Pfeifer L, Shaw GM, Preiser JC, Le Compte AJ, Lin J, Hewett D, Moorhead KT, Desaive T. Organ failure and tight glycemic control in the SPRINT study. Crit Care. 2010;14:R154.CrossRefPubMedPubMedCentral Chase JG, Pretty CG, Pfeifer L, Shaw GM, Preiser JC, Le Compte AJ, Lin J, Hewett D, Moorhead KT, Desaive T. Organ failure and tight glycemic control in the SPRINT study. Crit Care. 2010;14:R154.CrossRefPubMedPubMedCentral
11.
go back to reference Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129:644–50.CrossRefPubMed Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129:644–50.CrossRefPubMed
12.
go back to reference Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34:612–6.CrossRefPubMed Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34:612–6.CrossRefPubMed
13.
go back to reference Pretty CG, Le Compte AJ, Chase JG, Shaw GM, Preiser JC, Penning S, Desaive T. Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control. Ann Intensiv Care. 2012;2:17.CrossRef Pretty CG, Le Compte AJ, Chase JG, Shaw GM, Preiser JC, Penning S, Desaive T. Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control. Ann Intensiv Care. 2012;2:17.CrossRef
14.
15.
go back to reference Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.CrossRefPubMed Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.CrossRefPubMed
16.
go back to reference Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Can Med Assoc J. 2009;180:821–827.CrossRef Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Can Med Assoc J. 2009;180:821–827.CrossRef
17.
go back to reference Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA. Intensive insulin therapy and mortality in critically ill patients. Crit Care. 2008;12:R29.CrossRefPubMedPubMedCentral Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA. Intensive insulin therapy and mortality in critically ill patients. Crit Care. 2008;12:R29.CrossRefPubMedPubMedCentral
18.
go back to reference Kalfon P, Giraudeau B, Ichai C, Guerrini A, Brechot N, Cinotti R, Dequin PF, Riu-Poulenc B, Montravers P, Annane D, Dupont H, Sorine M, Riou B. Tight computerized versus conventional glucose control in the ICU: A randomized controlled trial. Intensive Care Med. 2014;40:171–81.CrossRefPubMed Kalfon P, Giraudeau B, Ichai C, Guerrini A, Brechot N, Cinotti R, Dequin PF, Riu-Poulenc B, Montravers P, Annane D, Dupont H, Sorine M, Riou B. Tight computerized versus conventional glucose control in the ICU: A randomized controlled trial. Intensive Care Med. 2014;40:171–81.CrossRefPubMed
19.
go back to reference Hamimy W, Khedr H, Rushdi T, Zaghloul A, Hosni M, Aal AA. Application of conventional blood glucose control strategy in surgical ICU in developing countries: Is it beneficial? Egypt J Anaesth. 2015;32(1):123–129.CrossRef Hamimy W, Khedr H, Rushdi T, Zaghloul A, Hosni M, Aal AA. Application of conventional blood glucose control strategy in surgical ICU in developing countries: Is it beneficial? Egypt J Anaesth. 2015;32(1):123–129.CrossRef
20.
go back to reference Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.CrossRefPubMed Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.CrossRefPubMed
21.
go back to reference Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc. 2010;85:217–24.CrossRefPubMedPubMedCentral Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc. 2010;85:217–24.CrossRefPubMedPubMedCentral
22.
go back to reference Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009;13:R91.CrossRefPubMedPubMedCentral Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009;13:R91.CrossRefPubMedPubMedCentral
23.
go back to reference Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108–18.CrossRefPubMed Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108–18.CrossRefPubMed
24.
go back to reference Chase JG, Le Compte AJ, Suhaimi F, Shaw GM, Lynn A, Lin J, Pretty CG, Razak N, Parente JD, Hann CE, Preiser J-C, Desaive T. Tight glycemic control in critical care-The leading role of insulin sensitivity and patient variability: a review and model-based analysis. Comput Methods Programs Biomed. 2011;102:156–71.CrossRefPubMed Chase JG, Le Compte AJ, Suhaimi F, Shaw GM, Lynn A, Lin J, Pretty CG, Razak N, Parente JD, Hann CE, Preiser J-C, Desaive T. Tight glycemic control in critical care-The leading role of insulin sensitivity and patient variability: a review and model-based analysis. Comput Methods Programs Biomed. 2011;102:156–71.CrossRefPubMed
25.
go back to reference Langouche L, Vander Perre S, Wouters PJ, D’Hoore A, Hansen TK, Van den Berghe G. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab. 2007;92:3890–7.CrossRefPubMed Langouche L, Vander Perre S, Wouters PJ, D’Hoore A, Hansen TK, Van den Berghe G. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab. 2007;92:3890–7.CrossRefPubMed
26.
go back to reference Thomas F, Pretty CG, Fisk L, Shaw GM, Chase JG, Desaive T. Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol. Biomed Eng Online. 2014;13:43.CrossRefPubMedPubMedCentral Thomas F, Pretty CG, Fisk L, Shaw GM, Chase JG, Desaive T. Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol. Biomed Eng Online. 2014;13:43.CrossRefPubMedPubMedCentral
27.
go back to reference Dickson JL, Gunn CA, Chase JG. Humans are horribly variable. Int J Clin Med Imaging. 2014;1(2). Dickson JL, Gunn CA, Chase JG. Humans are horribly variable. Int J Clin Med Imaging. 2014;1(2).
28.
go back to reference Fisk L, Lecompte A, Penning S, Desaive T, Shaw G, Chase G. STAR development and protocol comparison. IEEE Trans Biomed Eng. 2012;59:3357–64.CrossRefPubMed Fisk L, Lecompte A, Penning S, Desaive T, Shaw G, Chase G. STAR development and protocol comparison. IEEE Trans Biomed Eng. 2012;59:3357–64.CrossRefPubMed
29.
go back to reference Evans A, Le Compte A, Tan CS, Ward L, Steel J, Pretty CG, Penning S, Suhaimi F, Shaw GM, Desaive T. Stochastic targeted (STAR) glycemic control: design, safety, and performance. J Diabetes Sci Technol. 2012;6:102–15.CrossRefPubMedPubMedCentral Evans A, Le Compte A, Tan CS, Ward L, Steel J, Pretty CG, Penning S, Suhaimi F, Shaw GM, Desaive T. Stochastic targeted (STAR) glycemic control: design, safety, and performance. J Diabetes Sci Technol. 2012;6:102–15.CrossRefPubMedPubMedCentral
30.
go back to reference Lin J, Razak NN, Pretty CG, Le Compte A, Docherty P, Parente JD, Shaw GM, Hann CE, Geoffrey Chase J. A physiological intensive control insulin-nutrition-glucose (ICING) model validated in critically ill patients. Comput Methods Programs Biomed. 2011;102:192–205.CrossRefPubMed Lin J, Razak NN, Pretty CG, Le Compte A, Docherty P, Parente JD, Shaw GM, Hann CE, Geoffrey Chase J. A physiological intensive control insulin-nutrition-glucose (ICING) model validated in critically ill patients. Comput Methods Programs Biomed. 2011;102:192–205.CrossRefPubMed
31.
go back to reference Chase JG, Suhaimi F, Penning S, Preiser JC, Le Compte AJ, Lin J, Pretty CG, Shaw GM, Moorhead KT, Desaive T. Validation of a model-based virtual trials method for tight glycemic control in intensive care. Biomed Eng Online. 2010;9:84.CrossRefPubMedPubMedCentral Chase JG, Suhaimi F, Penning S, Preiser JC, Le Compte AJ, Lin J, Pretty CG, Shaw GM, Moorhead KT, Desaive T. Validation of a model-based virtual trials method for tight glycemic control in intensive care. Biomed Eng Online. 2010;9:84.CrossRefPubMedPubMedCentral
32.
go back to reference Lin J, Lee D, Chase JG, Shaw GM, Hann CE, Lotz T, Wong J. Stochastic modelling of insulin sensitivity variability in critical care. Biomed Signal Process Control. 2006;1:229–42.CrossRef Lin J, Lee D, Chase JG, Shaw GM, Hann CE, Lotz T, Wong J. Stochastic modelling of insulin sensitivity variability in critical care. Biomed Signal Process Control. 2006;1:229–42.CrossRef
33.
go back to reference Lin J, Lee D, Chase JG, Shaw GM, Le Compte A, Lotz T, Wong J, Lonergan T, Hann CE. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput Methods Programs Biomed. 2008;89:141–52.CrossRefPubMed Lin J, Lee D, Chase JG, Shaw GM, Le Compte A, Lotz T, Wong J, Lonergan T, Hann CE. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput Methods Programs Biomed. 2008;89:141–52.CrossRefPubMed
34.
go back to reference Krinsley JS, Preiser J-C. Time in blood glucose range 70–140 mg/dL  > 80% is strongly associated with increased survival in non-diabetic critically ill adults. Crit Care. 2015;19(1):179–189.CrossRefPubMedPubMedCentral Krinsley JS, Preiser J-C. Time in blood glucose range 70–140 mg/dL  > 80% is strongly associated with increased survival in non-diabetic critically ill adults. Crit Care. 2015;19(1):179–189.CrossRefPubMedPubMedCentral
35.
go back to reference Cerra FB, Benitez MR, Blackburn GL, Irwin RS, Jeejeebhoy K, Katz DP, Pingleton SK, Pomposelli J, Rombeau JL, Shronts E, Wolfe RR, Zaloga GP. Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest. 1997;111:769–78.CrossRefPubMed Cerra FB, Benitez MR, Blackburn GL, Irwin RS, Jeejeebhoy K, Katz DP, Pingleton SK, Pomposelli J, Rombeau JL, Shronts E, Wolfe RR, Zaloga GP. Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest. 1997;111:769–78.CrossRefPubMed
36.
go back to reference Finfer S, Wernerman J, Preiser J-C, Cass T, Desaive T, Hovorka R, Joseph JI, Kosiborod M, Krinsley J, Mackenzie I, Mesotten D, Schultz MJ, Scott MG, Slingerland R, Van den Berghe G, Van Herpe T. Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care. 2013;17:229.CrossRefPubMedPubMedCentral Finfer S, Wernerman J, Preiser J-C, Cass T, Desaive T, Hovorka R, Joseph JI, Kosiborod M, Krinsley J, Mackenzie I, Mesotten D, Schultz MJ, Scott MG, Slingerland R, Van den Berghe G, Van Herpe T. Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care. 2013;17:229.CrossRefPubMedPubMedCentral
38.
go back to reference Lonergan T, Le Compte A, Willacy M, Chase JG, Shaw GM, Hann CE, Lotz T, Lin J, Wong X-WW. A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients. Diabetes Technol Ther. 2006;8:449–62.CrossRefPubMed Lonergan T, Le Compte A, Willacy M, Chase JG, Shaw GM, Hann CE, Lotz T, Lin J, Wong X-WW. A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients. Diabetes Technol Ther. 2006;8:449–62.CrossRefPubMed
39.
go back to reference Preiser J-C, van Zanten AR, Berger MM, Biolo G, Casaer MP, Doig GS, Griffiths RD, Heyland DK, Hiesmayr M, Iapichino G, Laviano A, Pichard C, Singer P, Van den Berghe G, Wernerman J, Wischmeyer P, Vincent J-L. Metabolic and nutritional support of critically ill patients: consensus and controversies. Crit Care. 2015;19:1–11.CrossRef Preiser J-C, van Zanten AR, Berger MM, Biolo G, Casaer MP, Doig GS, Griffiths RD, Heyland DK, Hiesmayr M, Iapichino G, Laviano A, Pichard C, Singer P, Van den Berghe G, Wernerman J, Wischmeyer P, Vincent J-L. Metabolic and nutritional support of critically ill patients: consensus and controversies. Crit Care. 2015;19:1–11.CrossRef
40.
go back to reference Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland DK. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med. 2009;35:1728–37.CrossRefPubMed Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland DK. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med. 2009;35:1728–37.CrossRefPubMed
41.
go back to reference Arabi YM, Aldawood AS, Haddad SH, Al-Dorzi HM, Tamim HM, Jones G, Mehta S, McIntyre L, Solaiman O, Sakkijha MH, Sadat M, Afesh L. Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med. 2015;372(25):2398–2408.CrossRef Arabi YM, Aldawood AS, Haddad SH, Al-Dorzi HM, Tamim HM, Jones G, Mehta S, McIntyre L, Solaiman O, Sakkijha MH, Sadat M, Afesh L. Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med. 2015;372(25):2398–2408.CrossRef
42.
go back to reference Heyland DK, Cahill N, Day AG. Optimal amount of calories for critically ill patients: depends on how you slice the cake! Crit Care Med. 2011;39:1. Heyland DK, Cahill N, Day AG. Optimal amount of calories for critically ill patients: depends on how you slice the cake! Crit Care Med. 2011;39:1.
43.
go back to reference Amrein K, Ellmerer M, Hovorka R, Kachel N, Fries H, von Lewinski D, Smolle K, Pieber TR, Plank J. Efficacy and safety of glucose control with space glucose control in the medical intensive care unit—an open clinical investigation. Diabetes Technol Ther. 2012;14:690–5.CrossRefPubMed Amrein K, Ellmerer M, Hovorka R, Kachel N, Fries H, von Lewinski D, Smolle K, Pieber TR, Plank J. Efficacy and safety of glucose control with space glucose control in the medical intensive care unit—an open clinical investigation. Diabetes Technol Ther. 2012;14:690–5.CrossRefPubMed
44.
45.
go back to reference Rood E, Bosman R, Van der Spoel J, Taylor P, Zandstra D. Use of a computerized guideline for glucose regulation in the ICU improved both guideline adherence and glucose regulation. J Am Med Inform Assoc 2004;12(2):172–181.CrossRefPubMed Rood E, Bosman R, Van der Spoel J, Taylor P, Zandstra D. Use of a computerized guideline for glucose regulation in the ICU improved both guideline adherence and glucose regulation. J Am Med Inform Assoc 2004;12(2):172–181.CrossRefPubMed
46.
go back to reference Kulnik R, Plank J, Pachler C, Wilinska ME, Groselj-Strele A, Rothlein D, Wufka M, Kachel N, Smolle KH, Perl S, Pieber TR, Hovorka R, Ellmerer M. Evaluation of implementation of a fully automated algorithm (enhanced model predictive control) in an interacting infusion pump system for establishment of tight glycemic control in medical intensive care unit patients. J Diabetes Sci Technol. 2008;2:963–70.CrossRefPubMedPubMedCentral Kulnik R, Plank J, Pachler C, Wilinska ME, Groselj-Strele A, Rothlein D, Wufka M, Kachel N, Smolle KH, Perl S, Pieber TR, Hovorka R, Ellmerer M. Evaluation of implementation of a fully automated algorithm (enhanced model predictive control) in an interacting infusion pump system for establishment of tight glycemic control in medical intensive care unit patients. J Diabetes Sci Technol. 2008;2:963–70.CrossRefPubMedPubMedCentral
47.
go back to reference Boyd JC, Bruns DE. Chapter 16 Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests, vol. 467. 1st ed. Amsterdam: Elsevier; 2009. Boyd JC, Bruns DE. Chapter 16 Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests, vol. 467. 1st ed. Amsterdam: Elsevier; 2009.
48.
go back to reference Le Compte AJ, Pretty CG, Shaw GM, Chase JG. Glucometer accuracy and implications for clinical studies. Crit Care. 2012;16(Suppl 1):P173.CrossRefPubMedCentral Le Compte AJ, Pretty CG, Shaw GM, Chase JG. Glucometer accuracy and implications for clinical studies. Crit Care. 2012;16(Suppl 1):P173.CrossRefPubMedCentral
49.
go back to reference Arkray. GlucocardTM test strip 2 data sheet. Japan: Arkray Inc; 2007. Arkray. GlucocardTM test strip 2 data sheet. Japan: Arkray Inc; 2007.
50.
go back to reference Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed. 2005;77:259–70.CrossRefPubMed Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed. 2005;77:259–70.CrossRefPubMed
51.
go back to reference Roche Diagnostics. ACCU-CHEK comfort curve—test strip sheet. 2007:1–2. Roche Diagnostics. ACCU-CHEK comfort curve—test strip sheet. 2007:1–2.
Metadata
Title
Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis
Authors
Kent W. Stewart
Christopher G. Pretty
Hamish Tomlinson
Felicity L. Thomas
József Homlok
Szabó Némedi Noémi
Attila Illyés
Geoffrey M. Shaw
Balázs Benyó
J. Geoffrey Chase
Publication date
01-12-2016
Publisher
Springer Paris
Published in
Annals of Intensive Care / Issue 1/2016
Electronic ISSN: 2110-5820
DOI
https://doi.org/10.1186/s13613-016-0125-9

Other articles of this Issue 1/2016

Annals of Intensive Care 1/2016 Go to the issue